Stay updated with breaking news from Imdc Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Explore statistics behind and possible patient presentations of advanced renal cell carcinoma (RCC), with insight into IMDC risk stratification that may influence treatment strategies and outcomes.
The panel closes their discussion with a look at the standards for genetic counseling for patients with non-clear cell RCC.
The panel discusses the best approaches to treating patients with non-clear cell RCC.
Mehmet Asim Bilen, MD, explains how he would treat a patient with renal cell carcinoma who had disease progression after adjuvant therapy.
The panel discusses recent clinical trial data in the adjuvant treatment of metastatic renal cell carcinoma.